CANF — CAN-FITE BIOPHARMA LTD

Ownership history in SABBY MANAGEMENT, LLC  ·  2 quarters on record

This page tracks every 13F SEC filing in which SABBY MANAGEMENT, LLC reported a position in CAN-FITE BIOPHARMA LTD (CANF). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.48% (2025 Q2)
Avg. % of fund
1.25%
First filed
2025 Q2
Last filed
2025 Q3
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 1,406,050 +626,306 +80.3% 1.01% $870.6M $12.40
2025 Q2 INITIATED 779,744 — — 1.48% $818.7M $21.00
% of Fund (quarterly)    CANF price (monthly, adj. close)

Other funds also holding CANF

As of 2025 Q4 — sorted by position size

TWO SIGMA SECURITIES, LLC 3Y 7Y 0.0% Bogart Wealth, LLC 3Y 7Y 0.0% XTX Topco Ltd 3Y 0.0% Costello Asset Management, INC 3Y 7Y 0.0% RHUMBLINE ADVISERS 3Y 7Y 0.0% JANE STREET GROUP, LLC 3Y 7Y 0.0% OSAIC HOLDINGS, INC. 3Y 0.0% Activest Wealth Management 3Y 0.0% UBS Group AG 3Y 7Y 0.0% EverSource Wealth Advisors, LLC 3Y 0.0%
← Back to SABBY MANAGEMENT, LLC Holdings